A New Way to Treat Brain Tumors: Targeting Proteins Coded by Microcephaly Genes?

Autor:	Lang, Patrick Y., Gershon, Timothy R.
Předmět:	BRAIN tumors MICROCEPHALY NEURAL stem cells NEURAL development DEVELOPMENTAL neurobiology
Zdroj:	BioEssays; May2018, Vol. 40 Issue 5, p1-1, 14p
Abstrakt:	New targets for brain tumor therapies may be identified by mutations that cause hereditary microcephaly. Brain growth depends on the repeated proliferation of stem and progenitor cells. Microcephaly syndromes result from mutations that specifically impair the ability of brain progenitor or stem cells to proliferate, by inducing either premature differentiation or apoptosis. Brain tumors that derive from brain progenitor or stem cells may share many of the specific requirements of their cells of origin. These tumors may therefore be susceptible to disruptions of the protein products of genes that are mutated in microcephaly. The potential for the products of microcephaly genes to be therapeutic targets in brain tumors are highlighted hereby reviewing research on EG5, KIF14, ASPM, CDK6, and ATR. Treatments that disrupt these proteins may open new avenues for brain tumor therapy that have increased efficacy and decreased toxicity. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text